Differential tagging of RNA for preparation of a cell-free DNA/RNA sequencing library
In various aspects, the present disclosure provides methods, compositions, reactions mixtures, kits, and systems for sequencing both RNA and DNA from a single source sample. In some embodiments, RNA is treated so as to differentiate RNA sequences from DNA sequences derived from the same sample. In some embodiments, the RNA and DNA are cell-free polynucleotides.
1. A method of distinguishing sequences of RNA and DNA in a sample, the method comprising:
a. obtaining a sample comprising both RNA and DNA;
b. reverse transcribing the RNA to produce cDNA/RNA hybrid molecules;
c. degrading the RNA of the hybrid molecules to produce single-stranded cDNA;
d. preferentially joining a tag oligonucleotide comprising a tag sequence to the single-stranded cDNA in a reaction comprising a single-stranded DNA ligase to produce tagged cDNA;
e. sequencing the DNA and the tagged cDNA; and
f. using a processor to group RNA-derived sequences separately from DNA-derived sequences based on the presence or absence of the tag sequence, or a complement of the tag sequence;
wherein the reverse transcribing, preferentially joining, and sequencing are performed in the presence of the DNA.
2. The method of claim 1 , wherein the RNA and DNA are cell-free nucleic acids.
3. The method of claim 1 , further comprising identifying presence or absence of a condition of a subject based on the RNA-derived sequences and the DNA-derived sequences.
4. The method of claim 3 , wherein (i) the condition is cancer; or (ii) the method further comprises treating the subject based on the RNA-derived sequences and the DNA-derived sequences.
5. The method of claim 1 , wherein the reverse transcribing comprises extension of primers comprising a random sequence.
6. The method of claim 1 , wherein the reverse transcribing comprises extension of the cDNA of the hybrid along a template-switch oligonucleotide (TSO).
7. The method of claim 1 , wherein the tag oligonucleotide is joined to a 3′ end of the single-stranded cDNA.
8. The method of claim 1 , wherein the sequencing comprises amplifying the tagged cDNA to produce double-stranded tagged cDNA.
9. The method of claim 1 , wherein the sequencing comprises joining sequencing adapters to the tagged cDNA and the DNA.
10. The method of claim 1 , wherein the tag oligonucleotide comprises a unique molecular identifier (UMI), wherein each of a plurality of tagged cDNA molecules is distinguishable from others in the plurality of tagged cDNA molecules based on the UMI.
11. The method of claim 1 , wherein the sample is blood, a blood fraction, plasma, serum, saliva, sputum, urine, semen, transvaginal fluid, cerebrospinal fluid, or stool.
12. The method of claim 6 , wherein (i) the TSO comprises a universal switch primer sequence.
13. The method of claim 7 , wherein the tag oligonucleotide comprises a primer binding sequence.
14. The method claim 8 , wherein amplifying the tagged cDNA comprises extending a primer hybridized to the primer binding sequence.